期刊文献+

类叶升麻苷抗鱼藤酮致SH-SY5Y细胞损伤机制的研究 被引量:20

Neuroprotective effect of acteoside against rotenone-induced damage of SH-SY5Y cells and its possible mechanism
暂未订购
导出
摘要 目的研究类叶升麻苷抗鱼藤酮致多巴胺能神经元SH-SY5Y细胞损伤,对帕金森病相关蛋白Parkin、α-突触核蛋白(α-Synuclein,α-Syn)表达的影响,探讨类叶升麻苷抗细胞损伤的分子机制。方法化学比色法测定细胞培养液乳酸脱氢酶(lactate dehydrogenase,LDH)活性,蛋白质印迹法(Western blot)检测Parkin、α-Syn的表达,免疫荧光法检测SH-SY5Y细胞α-Syn分布。结果①类叶升麻苷(10,20或40mg.L-1)可明显降低鱼藤酮诱导的SH-SY5Y细胞乳酸脱氢酶(LDH)的释放;②0.5μmol.L-1的鱼藤酮处理SH-SY5Y细胞48h能引起Parkin蛋白的明显降解及α-Syn蛋白二聚体增加;③预先用类叶升麻苷(10,20或40mg.L-1)处理细胞,能够有效减少鱼藤酮诱导的Parkin蛋白的降解,呈浓度依赖性;并能够抑制鱼藤酮诱导的α-Syn蛋白二聚体增加及α-Syn阳性细胞数增加。结论类叶升麻苷对鱼藤酮致SH-SY5Y细胞损伤具有神经保护作用,其作用机制可能与减少Parkin蛋白的降解和抑制α-Syn蛋白的二聚体形成有关。 Aim To investigate the neuroprotective effect of acteoside against rotenone-induced cell damage in SH-SYSY cells and the effect of acteoside on the expression of Parkinson disease (PD) -related proteins Parkin and α-Synuclein (α-Syn), and to discover the underlying molecular mechanism of neuroprotection by acteoside. Methods The activity of lactate dehydrogenase(LDH) was measured by spectroscopy. Expressions of Parkin and α-Syn were studied using Western blot analysis, and the distribution of α-Syn was analyzed using immunofluorescence technique. Results (1) Acteoside (10, 20 or 40 mg· L^-1) pretreatment for 6 h markedly reduced the release of LDH induced by 0. 5 μmol· L^-1 rotenone; (2) Treatment with 0. 5 μmol· L^-1 rotenone for 48 h led to significant Parkin cleavage and increased formation of α-Syn protein dimer; (3) Pretreatment of SH-SYSY cells with acteoside ( 10, 20 or 40 mg·L^-1 ) for 6 h markedly reduced the cleavage of Parkin induced by 0.5 μmol· L^-1 rotenone in a concentration-dependent manner, inhibited the aggregation of α-Syn and decreased α-Syn-positive SH-SYSY cells. Conclusion These findings suggest that pretreatment of acteoside has a potent neuroprotective effect against rotenone-induced SH-SYSY cells damage and its mechanism might involve in reducing the cleavage of Parkin and inhibitng α-Syn expression induced by rotenone.
作者 高燕 蒲小平
出处 《中国药理学通报》 CAS CSCD 北大核心 2007年第2期161-165,共5页 Chinese Pharmacological Bulletin
基金 国家重点基础研究发展计划(973计划)项目子课题(No2004CB518902) 国家自然科学基金项目资助课题(No30472164)
关键词 类叶升麻苷 鱼藤酮 SH.SY5Y细胞 乳酸脱氢酶 PARKIN Α-突触核蛋白 acteoside rotenone SH-SYSY cells lac- tate dehydrogenase (LDH) Parkin α-Syn
  • 相关文献

参考文献13

  • 1Burch D,Sheerin F.Parkinson disease[J].Lancet,2005,365(9459):622-7.
  • 2Cookson M R.The biochemistry of Parkinson disease[J].Ann Rev Biochem,2005,74:29-52.
  • 3Ali Samii,John G Nt,Bruce R R.Parkinson disease[J].The Lancet,2004,363(9423):1783-93.
  • 4Staropoli J F,McDermott C,Martinat C,et al.Parkin is a component of an SCF-like ubiquitin ligase complex and protects post mitotic neurons from kainate excitotoxicity[J].Neuron,2003,37(5):735-49.
  • 5Feany M B,Bender W W.A Drosophila model of Parkinson disease[J].Nature,2000,404,394-8.
  • 6杨芳艳,蒲小平.类叶升麻苷对鱼藤酮致SH-SY5Y细胞凋亡的保护作用[J].中国药理学通报,2006,22(2):159-164. 被引量:17
  • 7Xiong Q,Tezuka Y,Kaneko T,et al.Inhibition of nitric oxide by phenylethanoids in activater macrophages[J].Eur J Pharmacol,2000,400:137-44.
  • 8Sheng G Q,Zhang J R,Pu X P,et al.Protection effect of verbascoside on 1-methyl-4-phenyl-pyridini-um ion-induced neurotoxicity in PC12 cells[J].Eur J Pharmacol,2002,451(2):119-24.
  • 9王立真,朱兴族.帕金森病致病的分子研究进展[J].中国药理学通报,2004,20(10):1081-1085. 被引量:12
  • 10Imai Y,Soda M,Takahashi R.Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity[J].J Bio Chem,2000,275 (46):35661-4.

二级参考文献27

  • 1MinDENG,Jin-yuanZHAO,Xiao-dongJU,Peng-feiTU,YongJIANG,Zheng-binLI.Protective effect of tubuloside B on TNFα-induced apoptosis in neuronal cells[J].Acta Pharmacologica Sinica,2004,25(10):1276-1284. 被引量:9
  • 2戚辰,刘振国,范国华,陈生弟,陆国强.鱼藤酮对多巴胺能神经元的神经毒性作用[J].中华神经科杂志,2004,37(6):538-542. 被引量:13
  • 3邓敏,赵金垣,屠鹏飞,姜永,陈静.松果菊苷对TNFα诱导的SH-SY5Y细胞凋亡的保护作用[J].中国药理学通报,2005,21(2):169-174. 被引量:34
  • 4Dawson TM, Dawson VL. Neuroprotective and neurorestorative strategies for Parkinson's disease[J]. Nat Neurosci, 2002, Suppl:1058-61.
  • 5Patterson SD,Spahr CS,Daugas E et al. Mass spectrometric identification of proteins released from mitochondria undergoing permeability transition[J]. Cell Death Differ, 2000, 7: 137-44.
  • 6Schapira AHV. Mitochondrial involvement in Parkinsons disease, Huntington's disease, hereditary spastic paraplegia and Friedrich's ataxia[J]. Biochim Biophys Acta, 1999, 1410:159-70.
  • 7Swerdlow RH, Parks JK, Miller SW et al.Origin and functional consequences of the complex I defect in Parkinsons disease[J]. Ann Neurol, 1996,40(4):663-71.
  • 8Walt JM, Nicodemus KK, Martin ER et al. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease[J]. Am J Hum Genet, 2003,72 (4):804-11.
  • 9McNaught KS, Olanow CW. Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinsons disease[J]. Ann Neurol, 2003, 53 (Suppl 3):73-84.
  • 10Auluck PK, Bonini NM. Pharmacological prevention of Parkinson disease in Drosophila[J]. Nat Med, 2002,8 (11):1185-6.

共引文献27

同被引文献186

引证文献20

二级引证文献200

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部